Evonik Venture Capital has sold its stake in Synoste Oy to Globus Medical. ... MORE
Evonik has significantly expanded its bio-based portfolio of active ingredients for cosmetic and personal care markets to meet growing demand for differentiated, sustainably sourced products. ... MORE
Despite the challenging macroeconomic environment, Evonik continues to withstand the crisis well. ... MORE
Evonik has established a comprehensive and integrated digital agenda to drive forward the digital transformation of its production and supply chain processes and the life cycle of its manufacturing facilities. ... MORE
Evonik is to cluster its MetAMINO® (DL-methionine) production at three international hubs (Americas, Europe, and Asia) to maximize economies of scale and utilize robust processes. ... MORE
Evonik is to cluster its MetAMINO® (DL-methionine) production at three international hubs (Americas, Europe, and Asia) to maximize economies of scale and utilize robust processes. ... MORE
